John F. Bierbaum

Direttore/Membro del Consiglio presso Holstein USA, Inc.

80 anni

Consumer Services

Health Technology

Profilo

John F.
Bierbaum has been a Director of Northfield Laboratories, Inc. since September 2002.
He is Chief Financial Officer of Archdiocese of Saint Paul and Minneapolis.
Mr. Bierbaum is a Director of Holstein USA, Inc. He was a Senior Officer of PepsiAmericas, Inc. Mr. Bierbaum had been a Consultant of PepsiAmericas, Inc. since May 2003.
He received a BS degree from the University of Minnesota in 1967 and is a Certified Public Accountant.

Posizioni attive di John F. Bierbaum

Società	Posizione	Inizio
Holstein USA, Inc.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di John F. Bierbaum

Precedenti posizioni note di John F. Bierbaum

Società	Posizione	Fine
Archdiocese of Saint Paul & Minneapolis Archdiocese of Saint Paul & Minneapolis Other Consumer ServicesConsumer Services Archdiocese of Saint Paul & Minneapolis operates elementary and secondary schools. The company was headquartered in St. Paul, MN.	Direttore Finanziario/CFO	03/12/2014
Northfield Laboratories, Inc. Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage.	Direttore/Membro del Consiglio	10/11/2009

Vedi nel dettaglio l'esperienza di John F. Bierbaum

Formazione di John F. Bierbaum

University of Minnesota

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John F. Bierbaum

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
Northfield Laboratories, Inc. Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage.	Health Technology
Holstein USA, Inc.
Archdiocese of Saint Paul & Minneapolis Archdiocese of Saint Paul & Minneapolis Other Consumer ServicesConsumer Services Archdiocese of Saint Paul & Minneapolis operates elementary and secondary schools. The company was headquartered in St. Paul, MN.	Consumer Services

Vedi le connessioni aziendali

Borsa valori
Insiders
John F. Bierbaum